Brind.

KeyBanc Capital Markets maintained an Overweight rating on GoodRx on June 24, 2025.

1 report, 0 independent Updated Jun 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

GoodRx

Keep exploring

The entities involved

GoodRx
American prescription drug price tracking website and app

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jun 24Unknown outlet